eleva GmbH

General information

eleva GmbH
Hans-Bunte-Str. 19
79108 Freiburg, Baden-Württemberg
Germany

Contact person: Jana Gross, Director Business Development
Company main phone: +49 (761) 470990
Company main fax: +49 (761) 47099191
Website: https://www.elevabiologics.com

Year founded:	1999
Source of foundation:	Independent foundation
No. of employees:	Worldwide: 30

Corporate description / mission:
eleva GmbH develops biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce antibodies, replacement enzymes, and fusion toxins. Eleva has successfully developed drug candidates into clinical phases.

State of ownership: Private / independent
Headquarters: HQ: Yes

Remarks on ownership / listings
Previously known as Greenovation Biotech GmbH

Categorization

Sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Antibodies
Antibody-drug-conjugate
Proteins

Primary therapeutic areas:

Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Business model:

Out-licensing
R&D
Research on contract basis

Customer segments:

Large biotech & big pharma
Small biotech

Summary Products / Services / Technologies

Number of Biotech Products

Pre-clinical:	4
Phase I:	1

Description of products:
Compleva FH /CPV-104
Compleva MFHR1/CPV-102
Repleva AGAL/RPV-001, etc.